搜尋結果
Note: As FDA indexes SPL, only VA MED-RT and NDF-RT Classifications that the FDA considers scientifically valid and clinically meaningful are used. Therefore, the drug classes that are available for a DailyMed query represent a subset of all VA MED-RT and
2021年9月15日 · The National Library of Medicine (NLM)’s DailyMed searchable database provides the most recent labeling submitted to the Food and Drug Administration (FDA) by companies and currently in use (i.e., "in use" labeling). DailyMed contains labeling for prescription and nonprescription drugs for human and animal use, and for additional products ...
Home News DailyMed Announcements Get RSS News & Updates FDA Resources NLM SPL Resources Download Data All Drug Labels All Indexing & REMS Files All Mapping Files SPL Image Guidelines Presentations & Articles Application Development Support
2020年4月17日 · Each tablet contains 324 mg of ferrous sulfate, equivalent to 65 mg of elemental iron, providing 362% of the U.S. recommended daily intake (RDI) of iron for adults and children 4 and older. Do not crush or chew tablets. Adult Serving Size: 1 tablet two to three times daily.
The DailyMed database contains labeling, submitted to the Food and Drug Administration (FDA) by companies, for the following products: The Prescribing Information (PI) for approved human prescription drug and biological products contains a summary of the essential scientific information needed for the safe and effective use of the product.
2023年10月31日 · SYNJARDY - SYNJARDY is a combination of empagliflozin and metformin hydrochloride (HCl) indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric ... 2 DOSAGE AND ADMINISTRATION. 2.1 Testing Prior to Initiation of SYNJARDY or SYNJARDY XR - Assess renal function before initiating SYNJARDY or SYNJARDY XR and ...
2024年6月7日 · TARPEYO (budesonide) delayed release capsules, for ... TARPEYO is indicated to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression. The recommended duration of therapy is 9 months, with a dosage of 16 mg administered orally once daily [see Clinical Studies (14.1 ...
